The future of oncological surgery relies on the development of scientific research skills, and the Surgical Oncology Research Programme offers a unique opportunity for clinical and academic growth, with a personalised doctoral path, a flexible curriculum, and ample opportunities for professional development, mentorship, and networking.

Over the past decade, interest in psychedelics—including psilocybin, LSD, and MDMA—as treatments for psychiatric disorders has grown exponentially among scientists, mental health professionals, the media, and the public.

During periods of low energy—such as intermittent fasting or exercise—immune cells step in to regulate blood sugar levels, acting as the “postman” in a previously unknown three-way conversation between the nervous, immune and hormonal systems. These findings open up new approaches for managing conditions like diabetes, obesity, and cancer.

Date and time:

20 January 2025 – 12:00

Location:

Champalimaud Foundation Auditorium

Description:

Conventional Dendritic Cells – Ecology, Diversity, and Functio

Carlos Minutti (Immunoregulation Lab)

Moderator: Cristina João (Myeloma Lymphoma Research Group)

Host

Rita Fior, PhD, Cancer Development and Innate Immune Evasion Lab

Venue

Seminar room

Osteosarcoma is a type of aggressive bone cancer that most commonly affects children and young adults between the ages of 10 and 20, during times of rapid bone growth. Although rare, it has a significant impact on young people and their families as treatment can require surgery or amputation. The cancer also has the potential to spread to other organs, most commonly the lungs. Because osteosarcoma is so genomically complex, it has been challenging to identify what genetic mutations drive the disease.